Articles and posts USelectAllNewsCEO Hanna Sjöström presenting the company in Aktieportföljen LiveOctober 14, 2022 | News, PresentationsNeola Medical’s new trademark has been registered in the European UnionOctober 13, 2022 | News, Non regulatoryBioStock highlights that the GASMAS-technology was examined in an article in Pediatric ResearchOctober 13, 2022 | NewsNew article by BioStock about Neola Medical and the rights issueOctober 12, 2022 | NewsNeola Medical presenting in Aktieportföljen LiveOctober 10, 2022 | News, PresentationsInterview with CEO Hanna Sjöström at NLSDays 2022October 6, 2022 | NewsCEO Hanna Sjöström presents rights issueOctober 5, 2022 | News, PresentationsNew scientific article in Pediatric Research shows the benefits of the technology used by Neola Medical for continuous lung monitoringOctober 5, 2022 | News, Non regulatoryCEO Hanna Sjöström in BioStock Investor PitchOctober 4, 2022 | News, PresentationsNeola Medical publishes prospectus in connection with the forthcoming rights issueSeptember 28, 2022 | News, Non regulatoryCEO Hanna Sjöström presents at Nordic Life Science Days 2022September 26, 2022 | NewsInterview with CEO Hanna Sjöström about the clinical study and the rights issueSeptember 22, 2022 | News, Presentations# 12345678910111213 $ For InvestorsWe are on a journey to revolutionize neonatal intensive careLearn more about investing in Neola Medical Join our journey
CEO Hanna Sjöström presenting the company in Aktieportföljen LiveOctober 14, 2022 | News, Presentations
Neola Medical’s new trademark has been registered in the European UnionOctober 13, 2022 | News, Non regulatory
BioStock highlights that the GASMAS-technology was examined in an article in Pediatric ResearchOctober 13, 2022 | News
New scientific article in Pediatric Research shows the benefits of the technology used by Neola Medical for continuous lung monitoringOctober 5, 2022 | News, Non regulatory
Neola Medical publishes prospectus in connection with the forthcoming rights issueSeptember 28, 2022 | News, Non regulatory
Interview with CEO Hanna Sjöström about the clinical study and the rights issueSeptember 22, 2022 | News, Presentations